0%
0 / 15 answered
Cancer Biology and Loss of Cell Cycle Control (2C) Practice Test
•15 QuestionsQuestion
1 / 15
Q1
A lab studied the Rb–E2F pathway in a cancer cell line. In normal cells, hypophosphorylated Rb binds E2F and limits transcription of S-phase genes; phosphorylation of Rb by cyclin D–CDK4/6 releases E2F. The cancer line expresses an Rb truncation that cannot bind E2F. When treated with a CDK4/6 inhibitor, the cancer cells show little change in S-phase gene expression, while a control line with intact Rb shows decreased S-phase gene expression and reduced proliferation. Which outcome is most consistent with these findings?
A lab studied the Rb–E2F pathway in a cancer cell line. In normal cells, hypophosphorylated Rb binds E2F and limits transcription of S-phase genes; phosphorylation of Rb by cyclin D–CDK4/6 releases E2F. The cancer line expresses an Rb truncation that cannot bind E2F. When treated with a CDK4/6 inhibitor, the cancer cells show little change in S-phase gene expression, while a control line with intact Rb shows decreased S-phase gene expression and reduced proliferation. Which outcome is most consistent with these findings?